Genetic diagnosis of patients with primary agammaglobulinemia treated at third level peruvian centers
DOI:
https://doi.org/10.17843/rpmesp.2019.364.4311Keywords:
Agammaglobulinaemia, Genotype, Bruton type agammaglobulinemia, PeruAbstract
Primary agammaglobulinemia result from specific alterations in B cells, which lead to low antibody production. Diagnostic suspicion is established with a history of repeated infections, low immunoglobulins, and absence of CD19+ B lymphocytes. The diagnosis is confirmed by genetic analysis and the detection of a mutation linked to the X or autosomal recessive or dominant chromosome. In Peru, there is no literature on primary agammaglobulinemia and no reports on the genotype of patients with suspected primary agammaglobulinemia. Under this scenario, a study was performed to describe the genotype of patients with suspected primary agammaglobulinemia. Twenty (20) patients were found with mutations in the BTK gene and an autosomal recessive IGHM mutation. Thirteen (13) hereditary mutations and seven de novo mutations were found. It is concluded that the group of primary agammaglobulinemia are mostly mutations in the BTK gene, corresponding to X-linked agammaglobulinemia.Downloads
Download data is not yet available.
Downloads
Published
2019-12-03
Issue
Section
Brief Report
License
Copyright (c) 2019 Revista Peruana de Medicina Experimental y Salud Pública
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
1.
Matos-Benavides E, Garcia-Gomero D, Inocente-Malpartida R, Córdova-Calderón W, Aldave-Becerra J. Genetic diagnosis of patients with primary agammaglobulinemia treated at third level peruvian centers. Rev Peru Med Exp Salud Publica [Internet]. 2019 Dec. 3 [cited 2024 Dec. 13];36(4):664-9. Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/4311